In vitro, PAR has been shown to prevent osteoclast formation and bone resorption [17], as well as inhibit the effects of IL-1β and TNF-α on human chondrocytes [18], which are key driving factors of RA pathogenesis. Here, IL1B is linked to rheumatoid arthritis.